Literature DB >> 15274696

5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.

Michael H Gold1, Mitchel P Goldman.   

Abstract

BACKGROUND: Photodynamic therapy, utilizing the topical administration of 20% 5-aminolevulinic acid, has generated a great deal of interest in the dermatology community over the past several years.
OBJECTIVE: The purpose of this article is to review the history of photodynamic therapy in dermatology and to review recent new advances with this technology that will increase its appeal to all dermatologists.
METHODS: A literature review and results of new clinical trials with regards to photorejuvenation and acne vulgaris treatments with 5-aminolevulinic acid photodynamic therapy are presented.
RESULTS: Short-contact, full-face 5-aminolevulinic acid photodynamic therapy treatments with a variety of lasers and light sources have shown to be successful in treating all facets of photorejuvenation and the associated actinic keratoses as well as disorders of sebaceous glands, including acne vulgaris. The treatments are relatively pain-free, efficacious, and safe. They are also making already available laser/light source therapies work better for acne vulgaris and photorejuvenation.
CONCLUSIONS: The use of 5-aminolevulinic acid photodynamic therapy with short-contact, full-face broad-application therapy is now able to bridge the world of medical and cosmetic dermatologic surgery. This therapy is available for all dermatologists to utilize in the care of their patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274696     DOI: 10.1111/j.1524-4725.2004.30331.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  15 in total

1.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT and MAL-PDT What Makes Them Different.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

2.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT in Clinical Practice How One Clinician Performs This Procedure.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2009-01

3.  Fractional resurfacing aiding photodynamic therapy of a recalcitrant plantar verruca: a case report and review of the literature.

Authors:  Michael H Gold; Amy Pope
Journal:  J Clin Aesthet Dermatol       Date:  2008-05

4.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part two of a five-part series: Lasers and Light Treatments for Acne Vulgaris Promising Therapies.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

5.  Intense Pulsed light Versus 1,064 Long-Pulsed Neodymium: Yttrium-Aluminum- Garnet Laser in the Treatment of Facial Acne Vulgaris.

Authors:  Essam Elden Mohamed; Khaled Tawfik; Mohamed Elsaie
Journal:  J Clin Diagn Res       Date:  2016-07-01

6.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

7.  The effect of multiple sequential light sources to activate aminolevulinic Acid in the treatment of actinic keratoses: a retrospective study.

Authors:  Daniel P Friedmann; Mitchel P Goldman; Sabrina G Fabi; Isabella Guiha
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

8.  The aesthetic applications of intense pulsed light using the Lumenis M-22 device.

Authors:  Yehuda Ullmann; Rania Elkhatib; Lucian Fodor
Journal:  Laser Ther       Date:  2011

Review 9.  Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

Authors:  Nathalie C Zeitouni; Neal Bhatia; Roger I Ceilley; Joel L Cohen; James Q Del Rosso; Angela Y Moore; Gilly Munavalli; David M Pariser; Todd Schlesinger; Daniel M Siegel; Andrea Willey; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

Review 10.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.